Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 314
- 试验地点
- 2
- 主要终点
- Self-reported 30 Day Smoking Abstinence
研究概览
简要总结
Thirty seven percent of adult male population smoke cigarettes in Qatar. The Global Youth Tobacco Survey also stated that 13.4% of male school students aged 13 to 15 years in Qatar smoke cigarettes. Smoking cessation is a key to reducing smoking related diseases and deaths. Health care providers are in an ideal position to encourage smoking cessation. Pharmacists are the most accessible health care providers and are uniquely situated to initiate behavior change among patients. Many western studies have shown that pharmacists can be successful in helping patients quit smoking. Studies demonstrating the effectiveness of pharmacist delivered smoking cessation programs are lacking in Qatar. This proposal aims to test the effect of a structured smoking cessation program delivered by trained ambulatory pharmacists in Qatar. A prospective, randomized, controlled trial will be conducted at 8 ambulatory pharmacies in Qatar. Participants will be randomly assigned to receive a 4-session face-to-face structured patient-specific smoking cessation program conducted by the pharmacist or 5 to 10 minutes of unstructured brief smoking cessation advice given by the pharmacist. Both groups will be offered nicotine therapy if feasible. The primary outcome of smoking cessation will be confirmed by exhaled carbon monoxide test at 12 months. If proven to be effective, this smoking cessation program will be considered as a model that Qatar and the region can apply to decrease smoking burden.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Control arm
Participants in the control group will receive 5-10 minutes of unstructured brief smoking cessation advice by the pharmacist. In addition they will be provided with educational materials about smoking cessation and will be offered nicotine replacement therapy (NRT).
干预措施: Control arm (i.e: regular care) (Other)
Intervention arm
Participants assigned to the intervention arm will participate in a face-to-face 4-session program at the pharmacy delivered by the study pharmacist at 2-4-week intervals over 8 weeks in addition to nicotine replacement therapy. The sessions will be set at a date and time that is convenient for both the pharmacist and the participant. The pharmacist will deliver the program at a time different from his or her pharmacy duty regular time.
干预措施: Pharmacist delivered smoking cessation program (Behavioral)
结局指标
主要结局
Self-reported 30 Day Smoking Abstinence
时间窗: 3 months
Self-reported 30-day point prevalence abstinence defined as having smoked no cigarettes in the last 30 days
Self-reported Continuous Abstinence at 3 Months
时间窗: 3 months
Self-reported continuous abstinence defined as having smoked no cigarettes since quit day
Objective Smoking Abstinence
时间窗: 12 months
Smoking abstinence as objectively verified by the CO exhaled test at 12 months
Self-reported 7-day Point Prevalence Abstinence
时间窗: 12 months
Defined as having smoked no cigarettes for the previous 7 days
Self-reported 30-day Point Prevalence Abstinence
时间窗: 12 months
Defined as having smoked no cigarettes in the last 30 days
Self-reported Continuous Abstinence
时间窗: 12 months
Defined as having smoked no cigarettes since quit day at 12 months
次要结局
- Health Related Quality of Life(6 month)
研究者
Dr. Maguy El Hajj
Assistant Professor and Chair/ Clinical Pharmacy and Practice Section
Qatar University
